Company intelligence / Profile preview

Thornton & Ross

Huddersfield, England, United Kingdomthorntonross.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Thornton & Ross has a broad commercial portfolio including leading UK consumer healthcare brands and prescription medicines. The company has expanded into specialty pharmaceuticals and biosimilars with recent launches such as the ustekinumab biosimilar Uzpruvo for Crohn’s disease and ulcerative colitis; ranibizumab biosimilar XIMLUCI for ophthalmic indications; teriparatide biosimilar MOVYMIA for osteoporosis; Kinpeygo for IgA nephropathy; and Fixkoh Airmaster inhaler for asthma/COPD. The company also maintains strong sales of established OTC brands like Covonia cough medicine.

Therapeutic areas
GastroenterologyPulmonologyCardiovascularPsychiatryMen's HealthMetabolic DisordersNephrologyOphthalmologyEndocrinologyImmunologyDermatologyOncologyNeurologyInfectious Diseases
Modalities
Small molecule (e.g., generics, OTC drugs)Biologic (biosimilars such as ustekinumab, ranibizumab, teriparatide)Device (inhalers for respiratory diseases)
Industry
Biotech
02

Drug pipeline

12 assets

Tixylix

Unknown

11 more assets in the full pipeline.

Request access →
03

Partnerships

Licensing agreement with Futura Medical to commercialize TPR100 diclofenac gel

Beyond the preview

Go deeper on Thornton & Ross.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thornton & Ross.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call